12 Jul Khiron Enters Exclusive Partnership with RAPPI, Latin America’s Largest Residence Multi-Vertical App Platform

Khiron Enters Exclusive Partnership with RAPPI, Latin America’s Largest Residence Multi-Vertical App Platform

News supplied by

Share this short article

  • Rappi could be the biggest house multi-Vertical software in Latin America , which received a USD 1 Billion investment from Softbank Group Corp. and Softbank Vision Fund, reaching unicorn status in 2019. Rappi runs in Brazil , Colombia , Mexico , Argentina , Chile , Costa Rica , Uruguay , Ecuador and Peru , which together represent a populace of over 600 million individuals.
  • Rappi’s multi-vertical application provides banking that is digital re re payment solutions, as well as anything from meals to pharmaceutical services and products, customer package products and courier solutions, with on average a lot more than 10 million active users month-to-month, in accordance with research company Apptopia.
  • Expansive contract begins having a 6-month exclusive circulation between Rappi and Khiron to introduce and circulate the business’s CPG product portfolio across Latin America through the Rappi platform.
  • Because of the possibility of future expansion, the partnership permits Khiron to introduce its CBD products atlanta divorce attorneys nation where Rappi has an existing existence, leveraging a quickly growing trend toward online product sales and last-mile distribution. The contract is anticipated to lessen general item launch and, logistics costs, increasing accessibility and experience of millions of customers, and increasing margins both for parties.
  • The Kuida TM in-app shop within Rappi was released in Colombia in might 2020 . The businesses want to expand circulation through RappiВґs consumer that is fast growing to Uruguay and Costa Rica , where Kuida was authorized, as well as other nations such as for instance Brazil , Mexico and Chile , susceptible to regulatory approvals.

TORONTO , Sept. 3, 2020 /PRNewswire/ – Khiron Life Sciences Corp. («Khiron» or even the «Company») (TSXV: KHRN), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically incorporated cannabis frontrunner with core operations in Latin America and European countries , announced today so it has entered into a distribution that is exclusive with Rappi SAS, the best Latin American last-mile multi-vertical platform this is certainly supported with a USD 1 billion investment from Softbank Group Corp., and Softbank Vision Fund. The expansive contract comprises a 6-month exclusive circulation partnership between Rappi and Khiron to introduce and circulate the business’s CPG item portfolio across Latin America through the Rappi platform, you start with Kuida TM , the business’s branded CBD skincare manufacturer product line, with all the potential to create in the partnership in the long run.

Beyond a typical merchant contract, this expanded partnership introduces the business’s CBD-based well-being items to an incredible number of Rappi users across Latin America through its advanced technology and advanced, customer-centric advertising methods. Aided by the Kuida store currently launched on Rappi in might 2020 for the market that is colombian circulation are going to be expanded to Uruguay and Costa Rica , where Kuida happens to be recently authorized. The organization also promises to introduce its manufacturer product line through Rappi’s fast consumer that is growing to nations such as for example Brazil , Mexico , Ecuador and Chile , susceptible to regulatory approvals.

Colombia’s Rappi may be the market leading multi-vertical application in Latin America having an existence in Brazil , Colombia , Mexico , Argentina , Chile , Ecuador , Costa Rica , Uruguay and Peru . Through its platform, clients purchase items and solutions and enjoy home distribution across multiple groups, including, medical, wellness, grocery, restaurants, pharmacies, beverage and expert services amongst others. In addition, the application form includes a wallet that is virtual RappiPay TM , where users will make P2P transfers and re re payments. Rappi has on love ru average significantly more than 10 million users that are active, according to research firm Apptopia, supplying deliveries for pretty much 100,000 companies in LatAm, including over 13 million deliveries in Colombia alone.

«Rappi may be the distribution brand name that everybody in Latin America understands and utilizes daily. The partnership with Rappi decreases our product launch and logistics expenses and transforms our supply and visibility to an incredible number of clients over the area. Rappi could be the last-mile distribution brand that helps us bring Khiron item to more clients than previously. We have been proud to determine this partnership that is first-of-its-kind both of these businesses, that are both industry leaders in LatAm, and had been both established by Colombians,» comments Alvaro Torres , Khiron CEO and manager.

«since the market for customer cannabis services and products globalizes it really is a normal complement us to partner with Khiron to meet up our software usersВґ needs. They are a recognized leader in the region, and an innovator in bringing quality products to market, «comments Simon Borrero , Rappi SAS CEO like us.

About Khiron Lifestyle Sciences Corp.

Khiron Life Sciences Corp. may be the principal built-in cannabis that are medical in Latin America . Khiron has core operations in Latin America , along side task in the united states and Europe , and is licensed in Colombia for the cultivation, manufacturing, domestic circulation, and worldwide export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. The organization delivers finest in course regulatory compliance, is completely authorized to produce and fill prescriptions for high- and low-THC medical cannabis in Colombia and contains the initial approved type of CBD aesthetic items on rack in Colombia, and obtainable in the usa together with uk .

The company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people with a focused regional strategy and patient oriented approach. The business is led by Co-founder and ceo, Alvaro Torres , as well as an executive that is experienced, and a qualified Board of Directors which includes previous President of Mexico , Vicente Fox .

Cautionary Notes

Forward-Looking Statements

This news release may include specific «forward-looking information» and «forward-looking statements» in the concept of relevant securities legislation. All information contained herein that isn’t historic in general may represent information that is forward-looking. Khiron undertakes no responsibility to comment analyses, objectives or statements created by third-parties in respect of Khiron, its securities, or financial or running outcomes (as relevant). Although Khiron thinks that the objectives reflected in forward-looking statements in this pr release are reasonable, such statement that is forward-looking been predicated on objectives, facets and assumptions concerning future occasions which might end up being inaccurate and tend to be susceptible to many dangers and uncertainties, specific of which are beyond Khiron’s control, like the risk factors talked about in Khiron’s yearly Information Form that is available on Khiron’s SEDAR profile at sedar . The information that is forward-looking in this news release is expressly qualified by this cautionary declaration and are usually made as of the date hereof. Khiron disclaims any intention and it has no responsibility or duty, except as needed for legal reasons, to upgrade or revise any forward-looking information, whether due to brand new information, future activities or else.

Neither the TSXV nor its Regulation Services Provider (as that term is defined into the policies for the TSXV) takes responsibility for the adequacy or precision with this pr release.